The present invention relates to new substituted prolinamides of general formula (I) wherein D, Y, A, B, R3, R4 and R5 are defined as in the specification, the tautomers, the enantiomers, the diastereomers, the mixtures thereof and the salts thereof, particularly the physiologically acceptable salts thereof with inorganic or organic acids or bases, which have valuable properties.
本发明涉及于新的取代脯
氨酰胺,其一般式为(I),其中D,Y,A,B,R3,R4和R5如规范中所定义,其互变异构体、对映异构体、顺反异构体、混合物及其与无机或有机酸或碱的生理上可接受的盐,具有有价值的性质。